Correlation Between Crinetics Pharmaceuticals and Janux Therapeutics | CRNX vs. JANX

Correlation Between Crinetics Pharmaceuticals and Janux Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Janux Therapeutics, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Janux Therapeutics.

Diversification Opportunities for Crinetics Pharmaceuticals and Janux Therapeutics

CrineticsJanuxDiversified AwayCrineticsJanuxDiversified Away100%
0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Crinetics and Janux is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Janux Therapeutics go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Janux Therapeutics

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the Janux Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Crinetics Pharmaceuticals is 4.03 times less risky than Janux Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Janux Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  4,901  in Janux Therapeutics on September 20, 2024 and sell it today you would earn a total of  1,060  from holding Janux Therapeutics or generate 21.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  Janux Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -20-100102030
JavaScript chart by amCharts 3.21.15CRNX JANX
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Crinetics Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Crinetics Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec50525456586062
Janux Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Janux Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Janux Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec40455055606570

Crinetics Pharmaceuticals and Janux Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-8.36-6.26-4.16-2.060.012.14.26.318.41 0.010.020.030.040.05
JavaScript chart by amCharts 3.21.15CRNX JANX
       Returns  

Pair Trading with Crinetics Pharmaceuticals and Janux Therapeutics

The main advantage of trading using opposite Crinetics Pharmaceuticals and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.
The idea behind Crinetics Pharmaceuticals and Janux Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital